Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) FCF Margin (2016 - 2025)

Historic FCF Margin for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to 15.25%.

  • Dexcom's FCF Margin fell 6300.0% to 15.25% in Q4 2025 from the same period last year, while for Dec 2025 it was 23.11%, marking a year-over-year increase of 74700.0%. This contributed to the annual value of 23.11% for FY2025, which is 74700.0% up from last year.
  • Per Dexcom's latest filing, its FCF Margin stood at 15.25% for Q4 2025, which was down 6300.0% from 47.91% recorded in Q3 2025.
  • In the past 5 years, Dexcom's FCF Margin ranged from a high of 47.91% in Q3 2025 and a low of 14.24% during Q1 2021
  • Its 5-year average for FCF Margin is 12.64%, with a median of 13.37% in 2022.
  • In the last 5 years, Dexcom's FCF Margin tumbled by -278800bps in 2021 and then skyrocketed by 390300bps in 2025.
  • Over the past 5 years, Dexcom's FCF Margin (Quarter) stood at 3.67% in 2021, then skyrocketed by 131bps to 8.46% in 2022, then decreased by -7bps to 7.84% in 2023, then soared by 103bps to 15.88% in 2024, then fell by -4bps to 15.25% in 2025.
  • Its FCF Margin stands at 15.25% for Q4 2025, versus 47.91% for Q3 2025 and 18.05% for Q2 2025.